《大行報告》瑞信上調中升(00881.HK)目標價至61元 評級維持「跑贏大市」
瑞信發表報告指,中升(00881.HK)兩個頂尖品牌平治及凌志在第三季錄良好增長,其中平治在中國的零售銷量由第二季的按上升21.6%,進一步加快到第三季的按年增長23.4%至近22.4萬輛。而凌志第三季在中國的零售銷量亦按年增長24.3%至6.3萬輛,對比第二季增長為18.9%。
該行預期,中升第三季整體高檔品牌的銷量按年上升逾30%,考慮及中檔品牌的銷售相對疲弱,估計集團第三季整體銷量按年增長15%。另外,由於第三季需求較預期強勁,該行預期集團今年全年奢侈品牌的銷量可按年增長16%。
瑞信輕微上調中升股份目標價至61元(原本60元),評級維持「跑贏大市」,並預計集團今年全年售後服務收入按年增長12%至200億元人民幣,因此調升其今年至2022年盈利預測0.6%至1.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.